華潤置地(01109.HK):前8月累計合同銷售金額達到1554億元
格隆匯9月12日丨華潤置地(01109.HK)發佈公吿,2024年8月,集團實現總合同銷售金額約人民幣152.0億元,總合同銷售建築面積約73.5萬平方米。2024年前8月累計合同銷售金額約人民幣1554.0億元,總合同銷售建築面積約667.5萬平方米。
2024年8月,集團經常性收入約人民幣40.0億元,按年增長12.2%,其中,經營性不動產業務租金收入約人民幣25.0億元,按年增長14.4%。2024年前8月累計經常性收入約人民幣306.7億元,按年增長13.9%,其中,經營性不動產業務租金收入約人民幣190.4億元,按年增長15.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.